Arch Therapeutics, Inc. (QB) Stock Price - ARTH

Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
SMALL CAP BASIC
Monthly Subscription
for only
$33.03
VAT not included
After Hours
Last Trade
Last: $ 0.28 ▼ -0.01 (-3.45%)
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Arch Therapeutics, Inc. (QB) ARTH OTC BB Common Stock Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.00% 0.29 0.2999 0.28 0.2801 0.29 17:00:09
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
59 363,756 $ 0.284804 $ 103,599 373,770 0.26 - 0.69
Last Trade Time Type Quantity Stock Price Currency
15:59:54 100 $ 0.29 USD

Arch Therapeutics, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 50.04M 172.56M $ -2.95M - -16.98 148.6M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Arch Therapeutics, Inc. (QB) News

Latest ARTH Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARTH Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.340.350.280.3112191k364k231k-0.05-14.71%
1 Month0.2750.3750.260.3121154k1M353k0.0155.45%
3 Months0.393750.430.260.318270k3M387k-0.10375-26.35%
6 Months0.5090.530.260.351824k3M295k-0.219-43.03%
1 Year0.470.690.260.399012k3M282k-0.18-38.30%
3 Years0.510.9450.250.550712k9M407k-0.22-43.14%
5 Years0.230.9450.150.45142k9M400k0.0626.09%

Arch Therapeutics, Inc. (QB) Description

Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's development stage product candidates include the Topical Gel and the Surgical Hemostatic Device.


Your Recent History
OTCBB
ARTH
Arch Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.